Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase.
Level V
Where this comes from
- Record sourced from PubMed, PMID 26098995.
- Also identified by DOI 10.1371/journal.pone.0130062 and PMC identifier 4476580.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The flavivirus methyltransferase (MTase) is an essential enzyme that sequentially methylates the N7 and 2'-O positions of the viral RNA cap, using S-adenosyl-L-methionine (SAM) as a methyl donor. We report here that small molecule compounds, which putatively bind to the SAM-binding site of flavivirus MTase and inhibit its function, were identified by using virtual screening. In vitro methylation experiments demonstrated significant MTase inhibition by 13 of these compounds, with the most potent compound displaying sub-micromolar inhibitory activity. The most active compounds showed broad spectrum activity against the MTase proteins of multiple flaviviruses. Two of these compounds also exhibited low cytotoxicity and effectively inhibited viral replication in cell-based assays, providing further structural insight into flavivirus MTase inhibition.
Medical subject headings
- Antiviral Agents
- Flavivirus
- Flavivirus Infections
- Methyltransferases
- Viral Nonstructural Proteins